Call for an instant quote 0345 90 80 161
Open Mon to Fri 09:00 - 17:30 | Sat 09:00 - 16:00 (GMT)
07 November 2014 09:36
Researchers have developed a new drug for asthma patients
Researchers have developed a drug that offers new hope to those suffering from asthma or chronic obstructive pulmonary disease (COPD).
The new medicine, called RPL554, works by blocking two enzymes in the body and can help to relax the airway muscles as well as reducing inflammation in sufferers.
Experts say the drug could revolutionise the treatment of asthma and COPD as it does not have any of the substantial side effects of current treatments.
A new treatment with minimal side-effects could encourage asthma sufferers to travel more - however before doing so they should be sure to arrange asthma travel insurance.
A trial carried out across three countries - the UK, the Netherlands and Italy - found that RPL554 relieves patients of symptoms and also has an an ti-inflammatory effect.
After a week of treatment, COPD patients were able to forcibly exhale a 17% higher volume of air after breathing in deeply than before.
The researchers said participants in the trial - both the placebo group and sufferers - had a good tolerance of the drug, and only mild side effects were noted.
RPL554 treatment also did not cause any of the stomach issues linked to current asthma and COPD drugs.
Treatments for these conditions have remained largely the same for the past four decades, although experts started to doubt their effectiveness after they were found to worsen asthma symptoms and fail to protect from flare ups.
What the experts at Asthma UK say
Dr Samantha Walker, director of research and policy at Asthma UK, described the new drug as "unique" because it has two effects at the same time.
She said the 250,000 people in the UK with severe asthma urgently need better medication, adding that current treatments come with a range of "unwelcome side effects" such as osteoporosis, sleep problems, weight gain and depression.
Asthma UK will watch the development of RPL554 "with great interest", Dr Walker said.
The findings of the study have been published in the journal The Lancet Respiratory Medicine.
15 August 2018
A simple blood test could help GPs detect a rare form of bone marrow cancer much earlier, a new study suggests.
[more...]
14 August 2018
Passengers arriving at Heathrow Airport last month faced queues of over two and a half hours at passport control, new figures have revealed.
11 August 2018
Hundreds of Ryanair flights will not take off as planned on Friday due to pilot strikes in five countries.
10 August 2018
Fad diets that cut out carbs while increasing fat consumption could lead to an increased risk of diabetes, according to new research.
09 August 2018
HIV testing has become even more accessible after a self-testing kit was made available from a High Street retailer.
08 August 2018
Women patients are more likely to survive a heart attack if they are treated by a female doctor, a new US study has revealed.
07 August 2018
The head of British Airways has branded two-hour queues facing travellers at Heathrow's passport control as a "border farce."
04 August 2018
Simple factors such as gender and body mass can help doctors to personalise care for patients with type 2 diabetes and avoid harmful side effects, according to a study.
03 August 2018
Gatwick Express must no longer claim it runs "non-stop to Victoria station in half an hour" and "in just 30 minutes" unless it can achieve the time in most cases, a watchdog has ruled.
02 August 2018
A charity is calling for greater access to respite support after it emerged that 72% of Britain's 700,000 young carers feel lonely and isolated during the summer holidays.
01 August 2018
A plan to build new rail links with Heathrow Airport and connect Windsor's two train stations have been submitted to the Government.
31 July 2018
The head of International Airlines Group (IAG), the company that owns British Airways, is 'optimistic' about a legal challenge to end crippling strikes.